Polymorphisms in estrogen related genes may modify the protective effect of isoflavones against prostate cancer risk in Japanese men

Tomoko Sonoda, Hiromu Suzuki, Mitsuru Mori, Taiji Tsukamoto, Akira Yokomizo, Seiji Naito, Kiyohide Fujimoto, Yoshihiko Hirao, Naoto Miyanaga, Hideyuki Akaza

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Soy isoflavones and estrogen related genes may play a major role in the etiology of prostate cancer. This study examined whether the genetic polymorphisms of estrogen receptors (ESR-α and ESR-β) and cytochrome P450 19A1 (CYP19A1) modified the protective effect of isoflavones against prostate cancer. One hundred and eighty cases and 177 controls were selected from three geographic areas of Japan. The odds ratio for more than or equal to 60 versus less than 60 mg/day of the intake of isoflavones was 0.63 (95% confidence interval=0.41-0.96). The TTTA long repeat was significantly associated with an increased risk (odds ratio=1.76, 95% confidence interval=1.15-5.70). The interaction between the polymorphisms and the intake of isoflavones on prostate cancer risk was analyzed by the multifactor dimensionality reduction method. The combination of the TTTA long repeats and the minor alleles of rs10046 in CYP19A1 and rs2077647 in ESR-α was a high risk for prostate cancer despite greater than or equal to 60 mg isoflavones/day. The combination of the TTTA short repeat and those homozygous for the major allele of rs10046 in CYP19A1 was low risk despite less than 60 mg isoflavones/day. In conclusion, the findings of this case-control study suggest that the protective effect of isoflavones may differ between the genotypes of estrogen related genes.

Original languageEnglish
Pages (from-to)131-137
Number of pages7
JournalEuropean Journal of Cancer Prevention
Volume19
Issue number2
DOIs
Publication statusPublished - Mar 1 2010

Fingerprint

Isoflavones
Prostatic Neoplasms
Estrogens
Genes
Cytochrome P-450 Enzyme System
Odds Ratio
Multifactor Dimensionality Reduction
Alleles
Confidence Intervals
Genetic Polymorphisms
Estrogen Receptors
Case-Control Studies
Japan
Genotype

All Science Journal Classification (ASJC) codes

  • Epidemiology
  • Oncology
  • Public Health, Environmental and Occupational Health
  • Cancer Research

Cite this

Polymorphisms in estrogen related genes may modify the protective effect of isoflavones against prostate cancer risk in Japanese men. / Sonoda, Tomoko; Suzuki, Hiromu; Mori, Mitsuru; Tsukamoto, Taiji; Yokomizo, Akira; Naito, Seiji; Fujimoto, Kiyohide; Hirao, Yoshihiko; Miyanaga, Naoto; Akaza, Hideyuki.

In: European Journal of Cancer Prevention, Vol. 19, No. 2, 01.03.2010, p. 131-137.

Research output: Contribution to journalArticle

Sonoda, T, Suzuki, H, Mori, M, Tsukamoto, T, Yokomizo, A, Naito, S, Fujimoto, K, Hirao, Y, Miyanaga, N & Akaza, H 2010, 'Polymorphisms in estrogen related genes may modify the protective effect of isoflavones against prostate cancer risk in Japanese men', European Journal of Cancer Prevention, vol. 19, no. 2, pp. 131-137. https://doi.org/10.1097/CEJ.0b013e328333fbe2
Sonoda, Tomoko ; Suzuki, Hiromu ; Mori, Mitsuru ; Tsukamoto, Taiji ; Yokomizo, Akira ; Naito, Seiji ; Fujimoto, Kiyohide ; Hirao, Yoshihiko ; Miyanaga, Naoto ; Akaza, Hideyuki. / Polymorphisms in estrogen related genes may modify the protective effect of isoflavones against prostate cancer risk in Japanese men. In: European Journal of Cancer Prevention. 2010 ; Vol. 19, No. 2. pp. 131-137.
@article{7500f9d476af482aacacd82faf2f0b81,
title = "Polymorphisms in estrogen related genes may modify the protective effect of isoflavones against prostate cancer risk in Japanese men",
abstract = "Soy isoflavones and estrogen related genes may play a major role in the etiology of prostate cancer. This study examined whether the genetic polymorphisms of estrogen receptors (ESR-α and ESR-β) and cytochrome P450 19A1 (CYP19A1) modified the protective effect of isoflavones against prostate cancer. One hundred and eighty cases and 177 controls were selected from three geographic areas of Japan. The odds ratio for more than or equal to 60 versus less than 60 mg/day of the intake of isoflavones was 0.63 (95{\%} confidence interval=0.41-0.96). The TTTA long repeat was significantly associated with an increased risk (odds ratio=1.76, 95{\%} confidence interval=1.15-5.70). The interaction between the polymorphisms and the intake of isoflavones on prostate cancer risk was analyzed by the multifactor dimensionality reduction method. The combination of the TTTA long repeats and the minor alleles of rs10046 in CYP19A1 and rs2077647 in ESR-α was a high risk for prostate cancer despite greater than or equal to 60 mg isoflavones/day. The combination of the TTTA short repeat and those homozygous for the major allele of rs10046 in CYP19A1 was low risk despite less than 60 mg isoflavones/day. In conclusion, the findings of this case-control study suggest that the protective effect of isoflavones may differ between the genotypes of estrogen related genes.",
author = "Tomoko Sonoda and Hiromu Suzuki and Mitsuru Mori and Taiji Tsukamoto and Akira Yokomizo and Seiji Naito and Kiyohide Fujimoto and Yoshihiko Hirao and Naoto Miyanaga and Hideyuki Akaza",
year = "2010",
month = "3",
day = "1",
doi = "10.1097/CEJ.0b013e328333fbe2",
language = "English",
volume = "19",
pages = "131--137",
journal = "European Journal of Cancer Prevention",
issn = "0959-8278",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Polymorphisms in estrogen related genes may modify the protective effect of isoflavones against prostate cancer risk in Japanese men

AU - Sonoda, Tomoko

AU - Suzuki, Hiromu

AU - Mori, Mitsuru

AU - Tsukamoto, Taiji

AU - Yokomizo, Akira

AU - Naito, Seiji

AU - Fujimoto, Kiyohide

AU - Hirao, Yoshihiko

AU - Miyanaga, Naoto

AU - Akaza, Hideyuki

PY - 2010/3/1

Y1 - 2010/3/1

N2 - Soy isoflavones and estrogen related genes may play a major role in the etiology of prostate cancer. This study examined whether the genetic polymorphisms of estrogen receptors (ESR-α and ESR-β) and cytochrome P450 19A1 (CYP19A1) modified the protective effect of isoflavones against prostate cancer. One hundred and eighty cases and 177 controls were selected from three geographic areas of Japan. The odds ratio for more than or equal to 60 versus less than 60 mg/day of the intake of isoflavones was 0.63 (95% confidence interval=0.41-0.96). The TTTA long repeat was significantly associated with an increased risk (odds ratio=1.76, 95% confidence interval=1.15-5.70). The interaction between the polymorphisms and the intake of isoflavones on prostate cancer risk was analyzed by the multifactor dimensionality reduction method. The combination of the TTTA long repeats and the minor alleles of rs10046 in CYP19A1 and rs2077647 in ESR-α was a high risk for prostate cancer despite greater than or equal to 60 mg isoflavones/day. The combination of the TTTA short repeat and those homozygous for the major allele of rs10046 in CYP19A1 was low risk despite less than 60 mg isoflavones/day. In conclusion, the findings of this case-control study suggest that the protective effect of isoflavones may differ between the genotypes of estrogen related genes.

AB - Soy isoflavones and estrogen related genes may play a major role in the etiology of prostate cancer. This study examined whether the genetic polymorphisms of estrogen receptors (ESR-α and ESR-β) and cytochrome P450 19A1 (CYP19A1) modified the protective effect of isoflavones against prostate cancer. One hundred and eighty cases and 177 controls were selected from three geographic areas of Japan. The odds ratio for more than or equal to 60 versus less than 60 mg/day of the intake of isoflavones was 0.63 (95% confidence interval=0.41-0.96). The TTTA long repeat was significantly associated with an increased risk (odds ratio=1.76, 95% confidence interval=1.15-5.70). The interaction between the polymorphisms and the intake of isoflavones on prostate cancer risk was analyzed by the multifactor dimensionality reduction method. The combination of the TTTA long repeats and the minor alleles of rs10046 in CYP19A1 and rs2077647 in ESR-α was a high risk for prostate cancer despite greater than or equal to 60 mg isoflavones/day. The combination of the TTTA short repeat and those homozygous for the major allele of rs10046 in CYP19A1 was low risk despite less than 60 mg isoflavones/day. In conclusion, the findings of this case-control study suggest that the protective effect of isoflavones may differ between the genotypes of estrogen related genes.

UR - http://www.scopus.com/inward/record.url?scp=76449096766&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=76449096766&partnerID=8YFLogxK

U2 - 10.1097/CEJ.0b013e328333fbe2

DO - 10.1097/CEJ.0b013e328333fbe2

M3 - Article

VL - 19

SP - 131

EP - 137

JO - European Journal of Cancer Prevention

JF - European Journal of Cancer Prevention

SN - 0959-8278

IS - 2

ER -